As patients experience all events, not just the first, researchers should consider adjusting their trials to capture all ...

Once again, data are suggesting that operators should move cautiously in bicuspid anatomy and think about surgery first.

The short follow-up period and elderly population may impact the trial’s prognostic significance and generalizability.

EMPOWER-CAD and BALI reinforce the utility of coronary lithotripsy, but the effect on hard outcomes is still unclear.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

Findings from the Chinese randomized trial support what most centers in the US are already doing, one expert says.

The findings from the Women’s Health Initiative are in line with recent guidelines for the primary prevention of stroke.

The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene ...

STEMI criteria alone aren’t perfect for identifying occluded arteries, but still some question the need for a new paradigm.

Researchers say the data underscore the need for more aggressive surveillance of patients, even when AS is moderate AS.

With the new analysis, researchers rule out embolic protection for stroke prevention in TAVI, but not everybody has given up.

Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.